Aficamten for drug-refractory severe obstructive hypertrophic cardiomyopathy in patients receiving disopyramide: REDWOOD-HCM cohort 3 - Owens, A T; Masri, A; Abraham, T P; REDWOOD-HCM INVESTIGATORS (J Card Fail, 2023)